VR Logo

Aurobindo Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 54,861.43 Cr

Revenue (TTM): R 24,461.65 Cr

Earnings (TTM): R 3,193.11 Cr

Cash: R 2,842.17 Cr

Total Debt: R 5,561.97 Cr

Promoters' ownership: 52.01%

Liquidity: High

52 Week range: R 288.85 - 996.85

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

  • CFO: 15,504.43 Cr
  • EBITDA: 26,293.18 Cr
  • Net Profit: 15,415.22 Cr

Stock Performance

Time Period Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
YTD1.602.691.63
1 month7.045.994.24
3 months18.2223.4212.12
1 Year92.3517.1059.81
3 Years12.4512.0513.87
5 Years2.8114.917.07
10 Years21.8310.0113.00
As on 15-Jan-2021
Year Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
2020101.1115.7561.45
2019-37.6914.38-3.55
20186.505.87-5.89
20172.7927.910.49
2016-24.061.95-12.88
201555.43-5.0315.06
2014189.9429.8947.43